Seenu Hariprasad to Glucocorticoids
This is a "connection" page, showing publications Seenu Hariprasad has written about Glucocorticoids.
Connection Strength
0.724
-
Discontinuous to continuous therapy for persistent diabetic macular edema leads to reduction in treatment frequency. Eur J Ophthalmol. 2021 Mar; 31(2):612-619.
Score: 0.152
-
Update on Emerging Steroid-Based Local Treatments for Noninfectious Uveitis. Ophthalmic Surg Lasers Imaging Retina. 2018 11 01; 49(11):828-831.
Score: 0.140
-
Treatments for Diabetic Macular Edema: Past, Present, and Future. Ophthalmic Surg Lasers Imaging Retina. 2016 09 01; 47(9):794-800.
Score: 0.120
-
Sustained delivery fluocinolone acetonide vitreous inserts provide benefit for at least 3 years in patients with diabetic macular edema. Ophthalmology. 2012 Oct; 119(10):2125-32.
Score: 0.090
-
Short-term intraocular pressure trends after intravitreal triamcinolone injection. Am J Ophthalmol. 2007 Feb; 143(2):365-7.
Score: 0.061
-
The 0.19-mg Fluocinolone Acetonide Implant for the Treatment of Diabetic Macular Edema: An Expert Consensus. Ophthalmic Surg Lasers Imaging Retina. 2023 03; 54(3):166-173.
Score: 0.047
-
Suprachoroidal Injection of Triamcinolone Acetonide Injectable Suspension for the Treatment of Macular Edema Associated With Uveitis in the United States: A Cost-Effectiveness Analysis. Value Health. 2022 10; 25(10):1705-1716.
Score: 0.046
-
Dexamethasone and Anti-VEGF Combination Therapy for the Treatment of Diabetic Macular Edema. Ophthalmic Surg Lasers Imaging Retina. 2019 01 01; 50(1):4-7.
Score: 0.035
-
Early Response to Intravitreal Dexamethasone Implant Therapy in Diabetic Macular Edema May Predict Visual Outcome. Am J Ophthalmol. 2017 Dec; 184:121-128.
Score: 0.033